--- title: "TELA Bio (TELA) stock listing, news and investor profile" url: "https://aibio.space/companies/tela-bio/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TELA Bio, Inc. (NASDAQ: TELA), United States. Listing facts, related biotech companies and news on aibio.space." --- TELA TELA Bio, Inc. NASDAQ · United States # TELA Bio (TELA) news Debt Financing · 2026-09-28 ## [TELA Bio gets lender consent to pause revenue covenant test](https://aibio.space/news/tela-bio-gets-lender-consent-pause-revenue-covenant-test/) The consent sets aside the minimum Revenue covenant for two quarters, through December 31, 2026. Perceptive Credit Holdings V, LP is administrative agent. ## Latest TELA Bio news We have not published a story on TELA Bio yet. When there is news, it will appear here. ## TELA Bio at a glance - **Ticker**: TELA - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $30.4 million ### Related companies - [ALLURION TECHNOLOGIES, INC.](https://aibio.space/companies/allurion-technologies/) OTC: ALUR - [Cresco Labs](https://aibio.space/companies/cresco-labs/) OTC: CRLBF - [INTUITIVE SURGICAL INC](https://aibio.space/companies/intuitive-surgical/) NASDAQ: ISRG - [Cytek Biosciences](https://aibio.space/companies/cytek-biosciences/) NASDAQ: CTKB - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) NYSE: EW - [MANNATECH INC](https://aibio.space/companies/mannatech/) NASDAQ: MTEX - [Integer Holdings](https://aibio.space/companies/integer/) NYSE: ITGR - [FAMILY OFFICE OF AMERICA, INC.](https://aibio.space/companies/family-office-of-america/) OTC: FOFA ### Also on NASDAQ - [Regeneron Pharmaceuticals](https://aibio.space/companies/regeneron-pharmaceuticals/) REGN - [Context Therapeutics](https://aibio.space/companies/context-therapeutics/) CNTX - [HeartBeam](https://aibio.space/companies/heartbeam/) BEATW - [IN8bio](https://aibio.space/companies/in8bio/) INAB - [Cingulate](https://aibio.space/companies/cingulate/) CING - [COMPASS Pathways Plc](https://aibio.space/companies/compass-pathways/) CMPS ## TELA Bio annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$80.3 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | [$69.3 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | | Research and development | [$9.2 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | [$8.8 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | | Net income (loss) | [-$38.8 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | [-$37.8 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | | Cash from operations | [-$28.2 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | [-$41.6 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | | Cash and equivalents | [$50.8 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926094039/) | [$52.7 million](https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $30.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about TELA Bio What is the ticker symbol of TELA Bio? TELA Bio, Inc. trades under the ticker TELA on NASDAQ. Where is TELA Bio listed? TELA Bio, Inc. is listed on NASDAQ. Which country or territory is TELA Bio listed under? Our directory records TELA Bio, Inc. under United States. Does aibio.space cover TELA Bio? aibio.space lists TELA Bio, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was TELA Bio's revenue last year? $80.3 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is TELA Bio profitable? TELA Bio, Inc. reported a net loss of $38.8 million for the fiscal year ended Dec 31, 2025, and used $28.2 million of cash in operations, per its annual report to the SEC. How much does TELA Bio spend on research and development? $9.2 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does TELA Bio have? $30.4 million in cash at Jun 30, 2026, per its 10-Q. What is the latest TELA Bio (TELA) stock news? Our latest story on TELA Bio, dated Sep 28, 2026: "TELA Bio gets lender consent to pause revenue covenant test". The consent sets aside the minimum Revenue covenant for two quarters, through December 31, 2026. Perceptive Credit Holdings V, LP is administrative agent. [Source](https://aibio.space/news/tela-bio-gets-lender-consent-pause-revenue-covenant-test/). Does TELA Bio have debt, a term loan or convertible notes? Our latest debt story, dated Sep 28, 2026: "TELA Bio gets lender consent to pause revenue covenant test". The consent sets aside the minimum Revenue covenant for two quarters, through December 31, 2026. Perceptive Credit Holdings V, LP is administrative agent. [Source](https://aibio.space/news/tela-bio-gets-lender-consent-pause-revenue-covenant-test/). How can I follow TELA Bio (TELA) news? Press Follow on this page to add TELA Bio to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming TELA Bio so far, in Debt Financing. ## Investor discussion: TELA Bio Members talk about TELA Bio (TELA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at TELA Bio, newest first. Each line links the filing it comes from. 1. 2026-10-08 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926114695/tm2627202d1_8k.htm) 2. 2026-09-18 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926108935/tm2625586d1_8k.htm) 3. 2026-09-14 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926107491/tm2624723-2_def14a.htm) 4. 2026-09-04 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926105492/tm2624723-1_pre14a.htm) 5. 2026-08-31 Distress Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.05,5.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926103548/tm2624299d1_ex99-1.htm) 6. 2026-08-11 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1561921/000110465926094039/tela-20260630x10q.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TELA on TradingView](https://www.tradingview.com/symbols/NASDAQ-TELA/). ## Listing details TELA Bio, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TELA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TELA Bio, Inc. - **Ticker**: TELA - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tela-bio/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TELA Bio (TELA) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/tela-bio/